-
The new definition excludes morbidly obese people from focusing on health
A new category of obesity has been recommended based on objective measures of illness. The first category is called ‘clinical obesity’, for people who already have a chronic disease associated with obesity. The second category is pre-clinical obesity and it means that a person has an increased risk of developing a health condition due to…
-
Is Obesity a Disease? It isComplicated in the Age of Ozempic
James Chen, a scientist from UT Southwestern Medical Center, US, has been awarded the Lasker Award for Medical Science for his work on obesity drugs. He was recognised for discovering how DNA triggered immune and inflammatory responses. In 2010, the US Food and Drug Administration had approved the first long-lasting GLP-1-based drugs, for type 2…
-
Is Obesity a disease in the age of Ozempic?
A recent study found that weight-loss drugs, like GLP-1, can reduce obesity in children aged 6–11 years. It showed 43% of those who took liraglutide showed a reduction in body fat, compared to 19% who took a placebo. However, the study didn’t include long-term data on the effects of GLP-1 mimics on growth and puberty…
-
Global condemnation toward Israel mounts as the U.S. faces a firefighter shortage
A former director of the American Board of Obesity Medicine has said that people using obesity medications as “short-term solution” to their diet problems can confuse them. Rekha Kumar, who served as the board’s director, said, “People are posting on social media about using obesity medication as short-term solution to their diet problems…So there are…
-
The FDA approved a weight loss drug
US’ Eli Lilly has received Food and Drug Administration’s approval to sell its weight-loss medication Zepbound. The drug is designed to be given at the highest dose of 15 milligrams per day. In a study, people who took it lost an average of 48 pounds, compared to a placebo group’s loss of 22 pounds. Over…
-
The drugs that have come to light are the breakthrough obese drugs
Wegovy was approved by the US Food and Drug Administration (FDA) for the treatment of obesity within six months of its approval. It is the first drug to be approved for the treatment of obesity by the FDA in 11 years. The drug’s effectiveness was tested in a clinical trial that found that it led…
-
The drugs that have surprised researchers are the breakthrough weight loss drugs.
Semaglutide, a drug used to treat diabetes, was approved by the US Food and Drug Administration (FDA) in 2021 for weight loss for adults with obesity. It was approved for use in patients with type 2 diabetes who’re at high risk of developing complications from the disease. It is also used to treat heart disease…
-
Don’t listen to sleep experts.
A study by researchers from the Johns Hopkins University found that people who sleep less than seven hours a night have more chronic diseases such as obesity and high blood pressure. Researchers also found that people who sleep less than six hours a night have more chronic diseases such as obesity and blood pressure. According…